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Abstract: 
Heterocyclic compounds are present in most biologically active molecules. The chemistry of 
heterocyclic compounds has been an interesting field of study. Heterocyclic nucleus 1,3,4 -thiadiazole 
constitutes constitutes an important class of compounds for drug development. The novel thiadiazoles 
and investigation of their chemical and biological behavior have gained more importance in recent 
decades. There has been intense investigation of different classes of thiadiazole compounds, many of 
which possess extensive pharmacological activities. The 1,3,4-thiadiazole nucleus is one of the most 
important and well-known heterocyclic nuclei, which is a common and integral feature of a variety of 
natural products and medicinal agents. Thiadiazole nucleus is present as a core structural component in 
an array of drug categories. The broad and potent activity of thiadiazole and their derivatives has 
established them as pharmacologically significant scaffolds. 1,3,4 -Thiadiazole nucleus exhibited 
remarkable pharmacological activities Such as antibacterial, antifungal, antitubercular, antiviral, 
antileishmanial, anti-inflammatory, analgesic, antidepressant, anticonvulsant, anticancer, antioxidant, 
antidiabetic, molluscicidal, antihypertensive, diuretic.  So far, modifications of the thiadiazole ring 
have proven highly effective with improved potency and lesser toxic ity. The present review highlights 
the recently synthesized thiadiazole possessing important biological activities.  
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Introduction  
The organic and medicinal chemistry is the design, synthesis and production of molecules having value as human 
therapeutic agents (Horton et al., 2003). Heterocyclic compounds are receiving special attention as they belong to 
a class of compounds with proven utility in medicinal chemistry. There are numerous biologically active 
molecules with five membered rings, containing three hetero atoms (Kamal et al., 2011). Heterocyclic 
compounds are cyclic compound with the ring containing carbon and other element, the component being 
oxygen, nitrogen and sulphur. Thiadiazole is a heterocyclic compound featuring both two nitrogen atom and one 
sulfur atom as part of the aromatic five-membered ring. Thiadiazole is an important scaffold known to be 
associated with several biological activities. Thiadiazoles occur in nature in four isomeric forms as 
1,2,3-thiadiazoles (a); 1,2,4-thiadiazole (b); 1,3,4-thiadiazole (c) and 1,3,5-thiadiazole (d) (Fig.1.). 
1,3,4-thiadiazole are important because of their versatile biological actions and compounds bearing thiadiazole 
nucleus have almost all types biological activities. Differently substituted thiadiazole moieties have also been 
found to have improved interesting activities such as analgesic, antimicrobial, antitubercular, anticonvulsant and 
anti-hepatitis B viral activities (Mishra et al., 2011). 
 
 
Figure1 Structure of isomeric thiadiazoles. 
 
Biological Activities of thiadiazoles 
Thiadiazoles are important class of heterocycles and have great interest because of their broad spectrum of 
biological activities. Different thiadiazole compounds having heterocyclic nucleus have been shown to possess 
different activities. Thiadiazoles associated with large number of biological activities such as many drugs 
containing thiadiazole nucleus such as acetazolamide, methazolamide, megazol and antibiotic cefozopram 
(Supuran and Scozzafava. 2001; Iizawa et al., 1993). 
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This review emphasizes on the biological activities of substituted thiadiazoles. There are several reports 
describing the thiadiazole derivatives for their various biological activities and recent studies have revealed that 
thiadiazole derivatives have a broad spectrum of pharmacological activities that can be classified into the 
following categories. 
Anticancer activity  
The 5-(3-indolyl)-1,3,4-thiadiazoles exhibited anticancer activity (Kumar et al., 2010). Some 
compounds were identified as potent agents for inducing cytoselective toxicity. It was found that 
substitution on C-2 position of the 1,3,4-thiadiazole ring plays an important role in imparting the 
cytotoxic activity to the compound. Replacement of phenyl ring at C-2 position with benzyl, 
4-(dimethylamino)phenyl, 3,4-dimethoxyphenyl and 4-benzyloxy group enhanced the 
antiproliferative activity, while replacement of the phenyl group with p -chlorophenyl and 
introduction of third methoxy group reduced the biological activity. Compound 
2-(4-(Benzyloxy)-5-(5-bromo-3-indolyl)-3-methoxyphenyl)-1,3,4-thiadiazole (1) with 4-benzyl- 
oxy- 3-methoxyphenyl at C-2 position and 5-bromoindole at C-5 position was found to be the most 
potent compound of the series. Compound (4-hydroxyphenyl)(5-(2,6-dichloro)-2-thioxo- 
1,3,4-thiadiazol-3-yl)methanone (2) showed broad spectrum of growth inhibition activity against 
human tumor cells and remarkable cytotoxic activity on nonsmall lung cancer (HOP 92), colon 
cancer (HCC-2998) and significant cytotoxic activity on prostate cancer (PC-3) study revealed that 
electron withdrawing group at position C-5 of thiadiazol was favorable for activity (Bhole and 
Bhusari. 2010). Derivatives of 2-arylamino-5-aryl-1,3,4-thiadiazoles evaluated in vitro cytotoxic 
activity and  revealed a cytotoxic effect of individual compounds on cancer cells of prostate (PC3, 
DU145, and LnCaP), breast (MCF7 and MDA-MB-231), and pancrease (PaCa2). The study showed 
that the 3,4,5-(OCH3)3C6H2 at C-5 position was responsible for binding to the Colchicine siteon 
tubulin and found to be favorable for activity. Further variation of C-2 arylamino group was 
associated with lesser degree of effect on the activity of 1,3,4-thiadiazoles. Most compounds were 
showed moderate activity and compound (3) displayed a greater potency toward pancreatic (PaCa2) 
cancer cell lines (Kumar et al., 2011). Quinolines derivatized with 1,3,4 -thiadiazole via cyclization 
of quinoline thiosemicarbazones and investigated for their cytotoxic activity against cervical cancer 
cell lines (Hela). Compounds (4) with methoxy at C- 6,7,8 of quinoline showed the potent 
anticancer activity and the cell lyses occurred only at 10 µg/mL (Marganakop et al., 2010). Several 
N1-acetylamino-(5-alkyl/aryl-1,3,4-thiadiazole-2-yl)-5-fluorouracil derivatives were evaluated for 
their anticancer activity on A-549 (human lung cancer cell), Bcap-37 (human breast cancer cell) by 
MTT assay. Compound (5) with electron with-drawing group attached to benzene ring was found to 
have activity against tested cell lines and possessed more potent antitumor inhibitory activity than 
5-fluorouracil (Zheng et al., 2008). Compound (E,E)-2,5-bis(4-(3-dimethyl–aminopropoxy) 
styryl)-1,3,4-thiadiazole (6) was found to be the most potent one by the MTT assay against A549, 
PC-3, and HA22T (Chou et al., 2003).  
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A number of N-substituted 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole derivatives were 
investigated as anti-proliferative agent against the four human cell lines: SW707 (rectal), HCV29T 
(bladder),  A549 (lung), and T47D (breast) as anticancer agents. Compound 2-(2,4-dichlorophenyl 
amino)-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole (7). The compounds with electron donating 
groups at C-terminal of the phenyl ring did not increased its cytoselective toxicity and the 
compounds with electron withdrawing groups (Cl,F) resulted in an increased activity by inducing 
cell death (Matysiak and Opolski. 2006). Compound 2-(4-fluorophenylamino)-5-(2,4-dihydroxy 
phenyl)-1,3,4-thiadiazole (8) inhibited proliferation of tumor cells derived from cancers of nervous 
system (medulloblastoma/rhabdosarcoma, neuroblastoma, and glioma) and peripheral cancers 
including colon adenocarcinoma and lung carcinoma (Rzeski et al., 2007). The effect of various 
substitution at 5-position of 2-(2,4 dihydroxy-phenyl)-1,3,4-thiadiazoles on antiproliferative 
activity against different human tumor cell lines. 2-(2,4-Dihydroxyphenyl)-5-(4-methoxy- 
benzyloxy)-1,3,4-thiadiazole (9) showed activity against HCV29T bladder cancer cell line 
(Matysiak et al., 2006). The 2,5-disubstituted 1,3,4-thiadiazoles possessing c-butenolide moiety, 
compound (10) was screened against Hela cell lines exhibited IC50 of 0.9 µM (Wei et al., 2009). 
Focal adhesion kinase (FAK) is a 125 kDa protein that was involved in multiple cellular functions 
like cell proliferation, survival, motility, invasion, metastasis, and angiogenesis. The inhibition of 
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FAK plays an important role in cancer therapy through decreased cellular viability, growth 
inhibition, or apoptosis. The FAK was proposed to be a potential therapeutic target in cancer. A 
series of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan and evaluated their activity as 
FAK inhibitors. The results of the inhibitory activity of the designed compounds showed that 
compound (11) possessed high potency against FAK (EC50=0.79 µM). Compound (12) showed 
EC50 values of 14.21–32.45 µg/mL against HEPG2, HELA, SW1116 and BGC823 cell lines. The 
study suggested that substitution with different acids led to different antitumor activity, and the 
potency order was phenylpropinic acid > phenylacetic acid > benzoic acid (Sun et al., 2011).  
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Anticonvulsent activity  
Although for the last twenty years new antiepileptic drugs have been introduced into clinical 
practice, the maximal electroshock (MES) test and the subcutaneous pentylenetetrazole ( scPTZ) 
test are the most widely used animal models of epilepsy to characterize the anticonvulsant activity 
(Locher and Schmidt. 2002). Some 2,5-Disubstituted 1,3,4-thiadiazoles were evaluated their 
potential anticonvulsant activity. Compound with 4-nitrophenyl-substituted semicarbazone (13) 
were the most active compound comparable with carbamzepine. The study suggested that 
(5-(4-substituted phenyl)-1,3,4-thiadiazol-2-yl) moiety as hydrophobic portion, two-electron donor 
atom and another hydrophobic distal aryl ring substituted with p-NO2 group responsible for 
metabolism, played a crucial role for its activity. The effect of electron withdrawing and electron 
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releasing groups on phenyl ring attached to thiazole and thiadiazole moiety on their anticonvulsant 
activity. Compound (14) having nitro group attached to the phenyl ring adjacent to the thiazole 
moiety demonstrated more potent anticonvulsant activity and the removal or replacement of –NO2 
function by a -Cl, -Br moieties was responsible for loss of activity (Rajak et al., 2009; Siddiqui and 
Ahsan. 2011). 
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In an attempt to improve the potency and selectivity of 2,5-Disubstituted-1,3,4-thiadiazoles, a 
series of 2-(N-alkyl/aryl-Nacetylamino)-5-(3-acetyloxy-2-naphthyl)-1,3,4-thiadiazoles. Compound 
2-ethylamino-5-(3-hydroxy-2-naphthyl)-1,3,4-thiadiazole (15) showed 90% protection against 
PTZ-induced generalized convulsions. Further, substitution of ethyl and acetylation of thiadiazoles 
resulted in loss of activity. Compound 5-{2′-amino-5′-(3″-aminomethylene-2″- methyl-6″,8″- 
dibromoquinazolin-4″ (3″H)-onyl)-1′,3′,4′-thiadiazol-2′-yl}-2-thiobarbituric acid (16) showed high 
percentage protection 90% (50 mg/kg ip) in both MES and PTZ models (Dogan et al., 2002; 
Srivastava and Kumar. 2004). 
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A series of sulfonamides incorporating valproyl and other lipophilic moieties has been   study. 
The effect of different alkyl/arylcarboxamido/ sulfonamido/ureido moieties on the 5th position of 
1,3,4-thiadiazolesulfonamide on its anticonvulsant activity. Their findings revealed that the 
valproyl derivative of acetazolamide (5-valproylamido-1,3,4-thiadiazole-2-sulfonamide) (17) was 
the best in the series as it exhibited very strong anticonvulsant activity in an MES test in mice 
(Masereel et al., 2002). A series of 3-aryl amino/amino-4-aryl-5-imino-D2-1,2,4-thiadiazolines 
18(a-b) were evaluated against MES and scPTZ induced seizure models in mice (Gupta et al., 
2008). 
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The 2-Phenylamino-5-(4-pyridyl)-1,3,4-thiadiazole derivatives were evaluated for their 
anticonvulsant activity by MES method. Among of these compounds, compounds 19a-e  showed 
good activity (Yar and Akhter. 2009). A series of aromatic aldehyde imine derivative of 
2-thiobenzyl-1,3,4-Thiadiazole 20a-c were showed good anticonvulsant activity. The chlorobenzyl 
substituted compound showed the potent anticonvulsant activity against MES method (Ahamad and 
Yusuf. 2010). A series of new 3-(5-substituted phenyl-1,3,4-thiadiazol-2-yl)-2-styryl quinazoline 
-4(3H)-ones were evaluated for anticonvulsant activity in the MES induced seizures and 
scPTZ-induced seizure models. Compound 21a-c showed good anticonvulsant activity (Jatav et al., 
2008). 
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21a=C6H5 p-ClC6H4;  
21b=m-ClC6H4b-ClC6H4;  
21c=p-ClC6H4, N  
 
Anti-inflammatory activity (COX-inhibitors)  
Thiadiazole incorporated in different heterocyclic templates has been reported to possess potent 
anti-inflammatory activity. Most of the thiadiazole derivatives exert anti -inflammatory activity by 
inhibition of the enzyme involved in the first step of the conversion of arachidonic acid to 
prostaglandins (PGs). Anti-inflammatory activity of series of 5-(1-adamantyl)-1,3,4-thiadiazole 
derivatives, compound (22), substituted with propionic acid at 2nd position of 
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1,3,4-thiadiazoline-2-thiones, showed almost equal anti-inflammatory activity at 20 mg/kg to that 
of Indomethacin (5 mg/kg). Replacement of 2-propionic acid with acetic and 3-propionic acid was 
slightly detrimental to the anti-inflammatory activity. Several 2- amino-5-sulfanyl-1,3,4- 
thiadiazoles and concluded that the compounds were associated with lesser degree of anti - 
inflammatory activity when compared to indomethacin. Only compound 4-(5-(4-Fluorophenyl 
sulfanyl)-(1,3,4)thiadiazol-2-ylamino) benzene sulfona-mide (23) showed 65.90% inhibition after 3 
h at 56 mg/kg (body weight) dose and 66.40% protection in acetic acid induced inflammation in 
mice (Kadi et al., 2010; Sainy et al., 2009). The anti -inflammatory activity showed by 
2-aryl-3-{5-(((1,3,4)thiadiazino(6,5-b)indol-3-ylamino) methyl)-1,3,4-thiadiazol-2-yl}-1,3- 
thiazolidin-4-one/azetidin-2-one (24). Compound with 2-chlorophenyl group at C-4 of 
azetidin-2-one ring as substituent exhibited the most potent anti-inflammatory (41.23%) and 
analgesic activity (38%) at a dose of 50 mg/kg than that of their corresponding thiazolidinone 
compounds (Bhati and Kumar. 2008). Several 1,3,4- thiadiazole derivatives of biphenyl-4-yloxy 
acetic acid (25). All the compounds were screened for their anti-inflammatory and analgesic 
activity of varying degree from 27.27% to 63.63% at the dose of 10 mg/kg po (Kumar et al., 2008).  
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1,3,4-thiadiazole analogs of naproxen carriying a 4-bromophenyl amino group (26) at second 
position of the thiadiazole ring showed 78.02% inhibition in rat paw edema (Amir et al., 2007). The 
presence of the tolyl substituent on the sulfonamide moiety on 4th position of 1,3,4 -thiadiazole ring 
was found to be suitable for increasing the analgesic and anti -inflammatory activity. Substituent on 
the amide chain affected the activity which became more evident for example halogenated 
substituents on the para-position of the aromatic ring of the amide moiety improved the activity 
profile. Compound (28) with a p-fluoro phenyl substituent was the most active compound among 
the benzoyl sulfonamido derivatives (Schenone et al., 2006). 
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        Compound 27                                Compound 28 
1,3,4-thiadiazoles containing 5-methyl-2-benzoxazolinone derivatives and evaluated their 
anti-inflammatory activity. All the compounds exhibited anti -inflammatory activity (at 50 mg/kg 
p.o.) of varying degree from 53.2% to 85.3% in inhibition of edema (Salgin-Goksen et al., 2007). 
Compound (29) with methyl group showed analgesic activity similar to that of morphine and 
aspirin. Conversion of the amino group to the carbamate or phenylthioureido functionalities at 5th 
position of the 2-(5-amino-1,3,4-thiadiazol-2-ylthio)-N-(2,5-dihydro-2,3-dimethyl-5-oxo 
-1-phenyl-1H-pyrazol-4-yl)acetamide (30) decreased anti-inflammatory as well as analgesic 
activity (Rostom et al., 2009). 
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2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazole derivatives (31) were found to be associated 
with lesser degree of anti-inflammatory activity compared with indomethacin, while 
2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles appeared to exhibit good dose-dependent 
anti-inflammatory activity (Kadi et al., 2007). The spirothiadiazole derivative having 4 -nitrophenyl 
group (32) exhibited promising maximum activity in induced paw inflammation model using mice 
and leukocyte accumulation in a carrageenan pleurisy model in the rat. Significant decrease in 
activity was found for the compounds with the replacement of 4-nitrophenyl group with the 
4-bromophenyl and phenyl group (Hafez et al., 2008). 
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A new series of selective cox-2 inhibitors with 2-amino-5-sulfanyl-1,3,4-thiadiazole Derivatives 
33a-d were selective inhibitiors of COX-2 and potentiated the activity of COX-1 enzyme. The 
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presence of sulphonamide group is a required pharmacophore for selective inhibition of COX -2 
enzyme (Sharma et al., 2008). Compounds 34 (a-b) were evaluated for its anti-inflammatory 
activity. Due to the presence of 2,4-dichlorophenyl, 4-chloroprene, n-butyl amino and 
4-aminophenyl groups of triazolo-thiadiazole ring have high anti-inflammatory activity (Amir et al., 
2008). 
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A series of aromatic acids and aryl/ alkyl isothiocyanates substituted-1,2,4- 
triazolo(3,4-b)-1,3,4-thiadiazole derivatives 35a were (Amir et al., 2007) evaluated for 
anti-inflammatory activity. Among of these compounds 35a have showed higher antiinflammatory 
activity. 
Compound 36a by the compelte S-oxidation of correspounding methylsulfide derivatives performed 
by hydrogen per oxide and titanium trichloride and on the other hand oxidation of sulfide 
derivatives with m-choloro benzoic acid furnished the sulphoxide derivatives 36b and evaluates the 
activity of anti-inflammatory, analgesic, and antiplatelet properties(Varandas et al., 2005). 
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The 1,3,4-thiadiazole, that containing a phenylalnine moiety were synthesized by intramolecular 
cyclization of 1,4-thiosmicrbazides (37), and the compounds was evaluated by anti-inflammatory 
activity (Moise et al., 2009). The 1,3,4-thiadiazole derivatives of biphenyl-4-yloxy acetic acid (38) 
that are evaluated by anti-infalmmatory activity , analgesic activity (Kumar et al., 2008). A series 
of 2-trifluoromethyl/sulphonamido-5,6-diarylsubtituted imidazo(2,1-b-)-1,3,4-thiadiazole 
derivatives (39) have been evaluated by the vitro cyclooxgenage inhibitory activity against COX -2 
& COX-1enzyme (Gadad et al., 2008). 
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Carbonic anhydrase inhibitory activity  
1,3,4-Thiadiazole-2-sulfonamides were earlier known as carbonic anhydrase inhibitors. Carbonic 
anhydrase enzymes (CAs) are ubiquitous zinc enzymes. These enzymes catalyze the 
interconversion between carbon dioxide and the bicarbonate ion and are involved in crucial 
physiological processes connected with respiration and transport of CO 2/HCO3-between 
metabolizing tissues and the lungs, pH and CO2 homeostasis, electrolyte secretion in a variety of 
tissues and organs, biosynthetic reactions such as gluconeogenesis, lipogenesis, and ureagenesis, 
bone resorption, calcification, tumorigenicity and several other physiological and pathological 
processes. Inhibition of CAs would be clinically useful in the treatment of various diseases such as 
glaucoma, epilepsy, congestive heart failure, mountain sickness, gastric and duodenal ulcers, and 
other neurological disorders (Supuran. 2008; Krishnamurthy et al., 2008). Several 
(R)-/(S)-10-camphorsulfonyl-substituted aromatic/ heterocyclic sulfonamides and evaluated the 
inhibition of several mammalian isoforms of the zinc enzyme carbonic anhydrase. Compounds 
having R- and S-10-camphorsulfonyl moiety represented more susceptibility toward to inhibition 
against mitochondrial isoform hCA VA. Generally the R-enantiomer (40) was more active than the 
corresponding S-isomer (Maresca and Supuran. 2011). The inhibition of various sulfonamides and 
sulfamates on two b-carbonic anhydrases isolated from the bacterial pathogen Salmonella enterica 
serovar Typhimurium. Compound 3-Fluoro-5-chloro-4-aminobenzolamide (41) showed an 
inhibition constant of 51 nM against stCA 1 and of 38 nM against stCA 2, while acetazolamide 
inhibited stCA 1 and stCA2 with KI of 59 and 84 nM, respectively (Nishimori et al., 2011).  
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The thiadiazole derivatives were investigated as inhibitors of the cytosolic isozymes hCA I and II, as well 
as the tumor-associated isozyme hCA IX. Some compounds showed excellent inhibitory activities 
(Cecchi et al., 2004). Compound (42) showed maximum activity against the tested isoenzymes. The 
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sulfanilamides acylated at the 4-amino group with short aliphatic/aromatic moieties incorporating 2–6 
carbon atoms showed modest hCA XIV inhibitory activity which was found to be more potent than 
sulfanilamide. Compound (42) and (43) substituted with bromo and nitro group at 4th position of phenyl 
ring showed 3.15–4.10 times more effective than the lead compound acetazolamide (Ozensoy et al., 2005). 
Sulfanilamide derivatives incorporating heterocyclic amines like morpholine, piperidines, and piperazines, 
compound was exhibited much better inhibition of carbonic anhydrase isoenzymes than the parent 
compounds. Among sulfanilamide derivatives, the derivatives containing morpholine ring revealed best 
inhibitory activity (Turkmen et al., 2005). 
N
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N
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O
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NN
S
NH2
O O  
           Compound 41           Compound 42= R = Br;  Compound 43 = R = NO2  
Scozzafava and Supuran synthesized a series of sulfonamides incorporating bile acid moiety. A 
large number of such derivatives showed strong inhibitory activity against three isozymes of 
carbonic anhydrase, that is CA I, II and IV. SAR study revealed that heterocyclic sulfonamide 
attached to acylating moiety dehydrocholic acid (44) showed most active inhibitory activity against 
hCA II and bCA IV (Scozzafava and Supuran. 2002). Several pyrazole derivatives of 
5-amino-1,3,4-thiadiazole- 2-sulfonamide (45) were synthesized and their inhibitory activity 
against hydratase and esterase property of carbonic anhydrase isoenzymes hCA I and hCA II were 
studied. Derivatives showed more inhibitory activity than parent compounds, 
5-amino-1,3,4-thiadiazole-2-sulfonamide and acetazolamide (Kasımogullari et al., 2010). 
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      Compound 44                                    Compound 45 
Two series of halogenated sulfanilamide and aminobenzolamide containing one or two halogens (F, 
Cl, Br, I) were investigated for inhibitory activity against carbonic anhydrase isoenzymes hCA I, 
hCA II, hCA IV and hCA IX. Aminobenzyloamides were found to be more active than 
sulfonamides against hCA I, hCA II and hCA IV. Bromo derivatives were more active than fluoro 
derivatives which in turn were more active than iodo derivatives and least activity was observed in 
chloro derivatives. Different patterns were seen in activity against hCA IX. Both sulfanilamide and 
aminobenzolamide derivatives were found to be very potent inhibitors. 
3-Flouro-5-chloro-4-aminobenzenesulfonamide derivative of sulphonylthiadiazole (46) showed the 
best hCA IX inhibition which was two times more active than acetazolamide (Ilies et al., 2003). 
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Independent strains of H. pylori were obtained from different kinds of gastric mucosal lesions and 
from these hpCA (bacterial carbonic anhydrase) DNAs were cloned and sequenced. Library of 
sulfonamides was evaluated for inhibitory activity against hpCA. Derivatives of 
4-tert-butylphenylcarboxamido were found to be slightly less efficient in inhibiting hpCA than 
corresponding 4-tert-butylphenylsulfonamido derivatives. Compounds 5-(4-tert-butylphenyl- 
sulfonamido)-1,3,4-thiadiazole- 2-sulfonamide (47) and 5-(4-tert-butylphenylcarboxamido)- 
1,3,4-thiadiazole-2-sulfonamide (48) were found to be very strong inhibitors of hpCA with KI of 
12–13 nM (Nishimori et al., 2006). 
N
S
N
SO2NH2
O2SHN
H2N
X
Y   
N
S
N
N
H
S
O
O
SO2NH2
 
X= Cl, Br, I, F; Y=Cl, Br, I, F 
 Compound 46                           Compound  47 
A series of compounds first by reacting valproic acid with aromatic and heterocyclic sulfonmaides 
in the presence of carbodiimides and secondly reacting valproyl chloride with sulfonamide in the 
presence of base. Derivatives were evaluated for inhibitory action against carbonic anhydrase 
enzymes, namely hCA I, hCA II, and bCA IV. Data revealed that inhibitory activity of compounds 
was greatly influenced by nature of sulfonamide attached to valproyl moiety. 
5-Valproylamido-1,3,4-thiadiazole-2-sulfonamide (49) was found to be more effective than 
acetazolamide and methazolamide against all three enzymes (Masereel et al., 2002).  
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          Compound 48               Compound 49 
Other activities  
A series of novel small thiadiazoles as inhibitors of PDE7. Out of the synthesized compounds, 
derivatives with 4-CONH2 on benzene ring (50), 4-aminoquinazoline (51) and 2-methyl-4- 
aminoquinazoline (52) on C-5 of thiadiazole ring exhibited high PDE4 inhibitory activity with an 
IC50 value of 0.061, 0.027, and 0.0039 lM, respectively. They concluded that the 
4-amino-quinazoline derivatives along with hydrophobic steric bulk attached with nitrogen of C-2 
of thiadiazole showed an increase in activity because of its structural similarity with the adenine 
part of cAMP. Replacement of the cyclohexyl moiety with smaller ring was not as selective and 
found to be detrimental to the enzymatic activity (Vergne et al., 2004). Int roduction of an OH group 
on 3rd position of cyclohexyl group of (53) represented IC50 of 0.088 nM toward PDE7. 
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Modification of 4-CONH2 group with sulfonamide (54) significantly improved the pharmacokinetic 
profile and binding affinity for PDE7 (Vergne et al., 2004). 
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Compound 53                                        Compound 54 
Small molecules thiadiazole derivatives as c-Jun N-terminal kinase inhibitors, on the basis of a lead 
structure from high throughput screening, they identified that substitution on 2nd-position with 
either 2-methoxyethyl group, sec-butyl group or n-propyl group improved the pepJIP1 
displacement (DELFIA) and the kinase activity (LANTHA) assays (De et al., 2010). Compounds 
(55) showed an IC50 of 4.8 lM in the kinase assay substrate and it displaced pepJIP1 with an IC 50 of 
158 nM. Modification on 4-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)-5-(5-nitrothiazol -2-ylthio) 
-4H-1,2,4-triazol-3-ol which showed competitive inhibition of the interactions between JNK and 
pepJIP1 with an IC50 of 280 nM resulted the discovery of (56) which could bind at the JIP site with 
the nitrothiazol group crossing the ridge close to residues Arg127 and Cys163 of enzyme side with 
an IC50 of 239 nM (De et al., 2009). The 2-piperidinopiperidine-5-arylthiadiazoles as H3 
antagonists which lead to increase histamine levels by blocking the histaminergic neurons 
irreversibly and may be useful in treating obesity, diabetes as well as other CNS disorders such as 
cognitive disorders like Alzheimer’s and Parkinson’s disease. The o, m and p substituent such as 
polar groups OMe, CN, and COCH3 on phenyl ring increases the H3 receptor antagonistic activity. 
Further replacement of phenyl ring with 2-pyridyl was found to be favorable, while pyrimidine and 
pyrazole offered less activity. Compound (57) with 3-methoxy group at 2-pyridyl ring substituted 
on C-5 of thiadiazole was found to be the most active (Xiao et al., 2011).  
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Cytotoxic activity   
Compound 5-(-4-(4fluorobezoylolamino)phenyl)-2-subsitutedamino-1,3,4-thiadiazole (58) and 
evaluate the cytotoxic activity (Karakus et al., 2010). A series of N-substituted 2-amino-5- 
(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles (59) were evaluated for their antiproliferative activities 
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against human cancer cell lines. The cytotoxicity in vitro against the four human cell lines: SW707 
(rectal), HCV29T (bladder), A549 (lung), and T47D (breast) was determined. The highest 
antiproliferative activity was found for 2-(2,4-dichlorophenylamino) 5-(2,4-dihydroxy 
phenyl)-1,3,4-thiadiazole, with ID50 two times lower (SW707, T47D) than for cisplatin studied 
comparatively as the control compound (Matysiak and Opolski. 2006).  
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Compound 58                                       Compound 59                                                                                      
R= alkyl,aryl, morpholinoalkyl 
Antidiabetic activity  
Some thiadoazole compounds were evaluated for antidiabetic activity. These compounds 60 has 
shown significant to moderate antidiabetic activity (Pattan et al., 2009).  
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           Compound 60 
 
Conclusions  
Thiadiazole is a unique template that is associated with several biological activities. The potency of 
4-thiazolidinone nucleus is clearly evident from the clinically used drugs such as acetazolamide, 
methazolamide, and megazol. Though the antibacterial, antitubercular, carbonic anhydrase 
inhibitors and antiulcer are the major areas of clinical use, other potential targets are still to be 
explored. Most of the positions were explored for improving the activity profile of thiadiazole. The 
literature analyzed to provide a meaningful overview of the structural requirements for activity, 
wherever possible (Jain et al., 2013). 
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